Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1991-6-21
|
pubmed:abstractText |
Multiple injections of autologous blood were made around the basilar artery of rabbits through a silicone catheter placed into the prepontine cistern. The total blood injected was 3 ml/kg in aliquots of 0.5 to 0.8 ml over a 4-hour period. Control angiograms were obtained 7 days before this procedure. Groups of animals were examined by angiography on each of 9 days after the injections of blood. An angiogram was obtained 15 minutes after the first injection of blood, 20 seconds after the intra-arterial injection of a maximum dilating dose of papaverine. All surviving animals showed basilar artery narrowing, which was greatest 24 hours after the hemorrhage, when the vessel diameter was reduced to 54% of the control value. The narrowing then decreased to a reduction of about 30%, which was maintained throughout the rest of the study period. A papaverine-resistant component of narrowing was not seen until the 3rd day. It increased progressively to Day 9 when it represented 63% of the total. This model has a number of features that are reminiscent of human cerebrovasospasm, including the fact that there is an initial phase of narrowing that is completely reversed by an intra-arterially administered vasodilator, and a second phase beginning on Day 3 which exhibits a progressively increasing papaverine-resistant component.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0022-3085
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
74
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
951-5
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading | |
pubmed:year |
1991
|
pubmed:articleTitle |
Longitudinal time course of reversible and irreversible components of chronic cerebrovasospasm of the rabbit basilar artery.
|
pubmed:affiliation |
Department of Pharmacology, Vermont Center for Vascular Research, University of Vermont, Burlington.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|